Search


Current filters:





Start a new search
Add filters:

Use filters to refine the search results.


Results 31-40 of 41 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2016Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypesMachiela, M.; Lan, Q.; Slager, S.; Vermeulen, R.; Teras, L.; Camp, N.; Cerhan, J.; Spinelli, J.; Wang, S.; Nieters, A.; Vijai, J.; Yeager, M.; Wang, Z.; Ghesquières, H.; McKay, J.; Conde, L.; de Bakker, P.; Cox, D.; Burdett, L.; Monnereau, A.; et al.
2011SHP-1 expression accounts for resistance to imatinib treatment in Philadelphia chromosome-positive cells derived from patients with chronic myeloid leukemiaEsposito, N.; Colavita, I.; Quintarelli, C.; Sica, A.; Peluso, A.; Luciano, L.; Picardi, M.; Vecchio, L.; Buonomo, T.; Hughes, T.; White, D.; Radich, J.; Russo, D.; Branford, S.; Saglio, G.; Vaz de Melo, J.; Martinelli, R.; Ruoppolo, M.; Kalebic, T.; Martinelli, G.; et al.
2015Analysis of KRAS/NRAS mutations in a phase III study of panitumumab with FOLFIRI compared with FOLFIRI zlone as second-line treatment for metastatic colorectal cancerPeeters, M.; Oliner, K.; Price, T.; Cervantes, A.; Sobrero, A.; Ducreux, M.; Hotko, Y.; André, T.; Chan, E.; Lordick, F.; Punt, C.; Strickland, A.; Wilson, G.; Ciuleanu, T.; Roman, L.; Van Cutsem, E.; He, P.; Yu, H.; Koukakis, R.; Terwey, J.; et al.
2013Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney diseaseDe Zeeuw, D.; Akizawa, T.; Audhya, P.; Bakris, G.; Chin, M.; Christ-Schmidt, H.; Goldsberry, A.; Houser, M.; Krauth, M.; Lambers Heerspink, H.; McMurray, J.; Meyer, C.; Parving, H.; Remuzzi, G.; Toto, R.; Vaziri, N.; Wanner, C.; Wittes, J.; Wrolstad, D.; Chertow, G.; et al.
2018Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk diseaseBranford, S.; Wang, P.; Yeung, D.T.; Thomson, D.; Purins, A.; Wadham, C.; Shahrin, N.H.; Marum, J.E.; Nataren, N.; Parker, W.T.; Geoghegan, J.; Feng, J.; Shanmuganathan, N.; Mueller, M.C.; Dietz, C.; Stangl, D.; Donaldson, Z.; Altamura, H.; Georgievski, J.; Braley, J.; et al.
2017Developing a set of core outcomes for trials in hemodialysis: an international Delphi surveyEvangelidis, N.; Tong, A.; Manns, B.; Hemmelgarn, B.; Wheeler, D.C.; Tugwell, P.; Crowe, S.; Harris, T.; Van Biesen, W.; Winkelmayer, W.C.; Sautenet, B.; O'Donoghue, D.; Tam-Tham, H.; Youssouf, S.; Mandayam, S.; Ju, A.; Hawley, C.; Pollock, C.; Harris, D.C.; Johnson, D.W.; et al.
2012Common values in assessing health outcomes from disease and injury: Disability weights measurement study for the Global Burden of Disease Study 2010Salomon, J.A.; Vos, T.; Hogan, D.R.; Gagnon, M.; Naghavi, M.; Mokdad, A.; Begum, N.; Shah, R.; Karyana, M.; Kosen, S.; Farje, M.R.; Moncada, G.; Dutta, A.; Sazawal, S.; Dyer, A.; Seiler, J.; Aboyans, V.; Baker, L.; Baxter, A.; Benjamin, E.J.; et al.
2017Laparoscopy to predict the result of primary cytoreductive surgery in patients with advanced ovarian cancer: a randomized controlled trialRutten, M.; Van Meurs, H.; Van De Vrie, R.; Gaarenstroom, K.; Naaktgeboren, C.; Van Gorp, T.; Brugge, H.; Hofhuis, W.; Schreuder, H.; Arts, H.; Zusterzeel, P.; Pijnenborg, J.; Van Haaften, M.; Fons, G.; Engelen, M.; Boss, E.; Vos, M.; Gerestein, K.; Schutter, E.; Opmeer, B.; et al.
2013SMAD2, SMAD3 and SMAD4 mutations in colorectal cancerFleming, N.; Jorissen, R.; Mouradov, D.; Christie, M.; Sakthianandeswaren, A.; Palmieri, M.; Day, F.; Li, S.; Tsui, C.; Lipton, L.; Desai, J.; Jones, I.; McLaughlin, S.; Ward, R.; Hawkins, N.; Ruszkiewicz, A.; Moore, J.; Zhu, H.; Mariadason, J.; Burgess, A.; et al.
2015Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trialCADISS trial investigators,; Markus, H.; Hayter, E.; Levi, C.; Feldman, A.; Venables, G.; Norris, J.; Peycke, J.; Willson, M.; Hicks, C.; Hayter, E.; Madigan, J.; Clifton, A.; Menon, R.; Kennedy, F.; Khan, U.; Feldman, A.; Hollocks, M.; Markus, H.; King, A.; et al.